Hepatitis C Virus NS5A Inhibitor
DBCAT003507Therapeutic category
A DrugBank category of 6 drugs. 6 of them are approved.
What you can answer from here — as of March 15, 2022
Which targets do Hepatitis C Virus NS5A Inhibitor share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account